entered into an agreement to acquire AbC.R.O. (AbCRO), a contract research
organization operating in Central and Eastern Europe. As a result of the acquisition, PPD gains immediate entry into Romania, Bulgaria, Serbia, and Croatia with established infrastructure and expertise. PPD will also bolster its existing staff and operations in Poland, Russia, and Ukraine.
Founded in 2000, AbCRO provides a range of Phase II–IV clinical services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs. AbCRO employs more than 230 full-time professionals, many of whom have worked extensively with PPD over the past three years.